What’s Inside the Report?
- Abstract Analysis (200 abstracts total), including a breakdown by data type and an at-a-glance view of where the field is concentrating.
- Target trends, showing how the field continues to center on CD3-engaging T cell bispecifics, and where attention is shifting.
- New pipeline intelligence, with five novel bispecific assets identified through abstract screening and added to Beacon
- Abstract summaries in one place, including clinical and preclinical abstract summaries, and trial outline summaries, to support faster triage and follow-up.
You May Also Be Interested In…
Learn More About Bispecific
What is Beacon Bispecific?
- The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
- Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
